Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Rituximab in IgG4-Related Disease: A Phase 1-2 Trial
Brief Summary: The primary objective of this study is to evaluate the safety and effectiveness of rituximab in IgG4-RD.